Nearly half of working-age adults were inadequately insured in 2026, and half went without needed care due to cost, a Commonwealth Fund survey found.
|Articles|November 30, 2012
Supplements and Featured Publications
- A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia
A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia
Advertisement
Despite its efficacy for the treatment of postherpetic neuralgia, the potential benefits from treatment with gabapentin may be somewhat limited by its intrinsic properties. Gabapentin’s absorption characteristics—its active and saturable uptake within a narrow absorption window in the upper small intestine—pointed to the utility of a gastroretentive (GR) dosage form to improve the absorption of gabapentin at clinically relevant doses.
Information about the GR formulation of gabapentin is available in a recently released newsletter. To view the full newsletter, please click
Advertisement
Related to this article
Cross-ancestry GWAS of more than 1.8 million people flags SERPINA1, SMAD3, and other bronchiectasis targets shared with COPD and chronic bronchitis.
The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential.
ALIS added to azithromycin and ethambutol raised culture conversion in new MAC lung disease, with rare resistance, in an ENCORE analysis at IDWeek 2026.
A real-world trial found 42.6% of patients with severe hand eczema cleared on oral alitretinoin.
AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access.
IDWeek 2026 posters describe a rule-based tool classifying about 1 in 5 patients with cUTI as outpatient-eligible and 5 clusters with varied LOS.
Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance and other key measures.
Advertisement
Advertisement
Trending on AJMC
1
Awareness Gaps Drive Narcolepsy, IH Delays: Logan Schneider, MD
2
Extension Studies in TPIP Show Promise in PAH, PH-ILD
3
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
4
International Panel Agrees on Framework for Tapering Psoriasis Biologics
5